Sulfuretin, a major flavonoid isolated from Rhus verniciflua, ameliorates experimental arthritis in mice

Life Sciences

Volumn 90, Issue 19-20, 2012, Pages 799-807

  Lee, Young Rae ^a   Hwang, Jin Ki ^b   Koh, Hyoung Won ^b   Jang, Kyu Yun ^b   Lee, Ju Hong ^b   Park, Jin Woo ^b   Park, Byung Hyun ^b  

^a Wonkwang University   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

Collagen induced arthritis; Inflammation; Nuclear factor B; Rheumatoid arthritis; Sulfuretin; Synoviocytes

Indexed keywords

CHEMOKINE; COLONY STIMULATING FACTOR; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; SULFURETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; JOINT DESTRUCTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; POISON IVY; RHEUMATOID ARTHRITIS; RHUS VERNICIFLUA; SYNOVIOCYTE; SYNOVITIS;

ANIMALS; ANTIMETABOLITES; ARTHRITIS, RHEUMATOID; BENZOFURANS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES; COLLAGEN; CYTOKINES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLAVONOIDS; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED DBA; NF-KAPPA B; OSTEOCLASTS; RHUS; SYNOVIAL MEMBRANE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

MUS; TOXICODENDRON VERNICIFLUUM;

EID: 84860770445     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.04.015     Document Type: Article

References (34)

1. W.J. Boyle, W.S. Simonet, and D.L. Lacey Osteoclast differentiation and activation Nature 423 2003 337 342 (Pubitemid 40852708)
2. T. Braun, and J. Zwerina Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis Arthritis Res Ther 13 2011 235
3. I.K. Campbell, S. Gerondakis, K. O'Donnell, and I.P. Wicks Distinct roles for the NF-κB1 (p50) and c-Rel transcription factors in inflammatory arthritis J Clin Invest 105 2000 1799 1806 (Pubitemid 30421761)
4. J. Choi, B.J. Yoon, Y.N. Han, K.T. Lee, J. Ha, and H.J. Jung Antirheumatoid arthritis effect of Rhus verniciflua and of the active component, sulfuretin Planta Med 69 2003 899 904 (Pubitemid 38005444)
5. M. Feldmann, F.M. Brennan, and R.N. Maini Role of cytokines in rheumatoid arthritis Annu Rev Immunol 14 1996 397 440 (Pubitemid 26130190)
6. J.H. Gong, R. Yan, J.D. Waterfield, and I. Clark-Lewis Post-onset inhibition of murine arthritis using combined chemokine antagonist therapy Rheumatology 43 2004 39 42 (Pubitemid 38088366)
7. M.J. Green, A.K. Gough, J. Devlin, J. Smith, P. Astin, and D. Taylor Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis Rheumatology 42 2003 83 88 (Pubitemid 36131572)
8. Y.S. Hah, Y.R. Lee, J.S. Jun, H.S. Lim, H.O. Kim, and Y.G. Jeong A20 suppresses inflammatory responses and bone destruction in fibroblast-like synoviocytes and collagen-induced arthritic mice Arthritis Rheum 62 2010 2313 2321
9. M.L. Handel, L.B. McMorrow, and E.M. Gravallese Nuclear factor-κB in rheumatoid synovium. Localization of p50 and p65 Arthritis Rheum 38 1995 1762 1770 (Pubitemid 26010277)
10. A. Israel The IKK complex: an integrator of all signals that activate NF-κB? Trends Cell Biol 10 2000 129 133 (Pubitemid 30171300)
11. W.K. Jeon, J.H. Lee, H.K. Kim, A.Y. Lee, S.O. Lee, and Y.S. Kim Anti-platelet effects of bioactive compounds isolated from the bark of Rhus verniciflua Stokes J Ethnopharmacol 106 2006 62 69 (Pubitemid 43732486)
12. L.A. Joosten, M.M. Helsen, T. Saxne, F.A. van De Loo, D. Heinegard, and W.B. van Den Berg IL-1αβ blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation J Immunol 163 1999 5049 5055 (Pubitemid 29501273)
13. Y. Juarranz, C. Abad, C. Martinez, A. Arranz, I. Gutierrez-Canas, and F. Rosignoli Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis Arthritis Res Ther 7 2005 R1034 R1045
14. A.E. Koch Chemokines and their receptors in rheumatoid arthritis: future targets? Arthritis Rheum 52 2005 710 721 (Pubitemid 40365092)
15. J.C. Lee, K.T. Lim, and Y.S. Jang Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties Biochim Biophys Acta 1570 2002 181 191
16. Y.R. Lee, J.H. Lee, E.M. Noh, E.K. Kim, M.Y. Song, and W.S. Jung Guggulsterone blocks IL-1β-mediated inflammatory responses by suppressing NF-κB activation in fibroblast-like synoviocytes Life Sci 82 2008 1203 1209
17. Y.R. Lee, S.H. Kweon, K.B. Kwon, J.W. Park, T.R. Yoon, and B.H. Park Inhibition of IL-1β-mediated inflammatory responses by the IκBα super-repressor in human fibroblast-like synoviocytes Biochem Biophys Res Commun 378 2009 90 94
18. Y.R. Lee, J.K. Hwang, H.S. Lee, Y.J. Cheon, J.H. Ryu, and S.I. Lee SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast-like synoviocytes and mice with collagen-induced arthritis Br J Pharmacol 164 2011 794 806
19. I. Marty, V. Peclat, G. Kirdaite, R. Salvi, A. So, and N. Busso Amelioration of collagen-induced arthritis by thrombin inhibition J Clin Invest 107 2001 631 640 (Pubitemid 32205184)
20. I.B. McInnes, and G. Schett Cytokines in the pathogenesis of rheumatoid arthritis Nat Rev Immunol 7 2007 429 442 (Pubitemid 46834849)
21. P. Miossec An update on the cytokine network in rheumatoid arthritis Curr Opin Rheumatol 16 2004 218 222 (Pubitemid 38530489)
22. P. Miossec Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified Arthritis Rheum 56 2007 2111 2115 (Pubitemid 47173557)
23. U. Muller-Ladner, T. Pap, R.E. Gay, M. Neidhart, and S. Gay Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis Nat Clin Pract Rheumatol 1 2005 102 110
24. K.Y. Park, G.O. Jung, K.T. Lee, J. Choi, M.Y. Choi, and G.T. Kim Antimutagenic activity of flavonoids from the heartwood of Rhus verniciflua J Ethnopharmacol 90 2004 73 79 (Pubitemid 38091689)
25. C. Ribbens, B. Andre, J.M. Jaspar, O. Kaye, M.J. Kaiser, and D. De Groote Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis J Rheumatol 27 2000 888 893 (Pubitemid 30389742)
26. M.G. Ruocco, S. Maeda, J.M. Park, T. Lawrence, L.C. Hsu, and Y. Cao IκB kinase (IKK) β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss J Exp Med 201 2005 1677 1687 (Pubitemid 40721011)
27. S. Shahrara, A.E. Proudfoot, J.M. Woods, J.H. Ruth, M.A. Amin, and C.C. Park Amelioration of rat adjuvant-induced arthritis by Met-RANTES Arthritis Rheum 52 2005 1907 1919 (Pubitemid 40852900)
28. M.Y. Song, G.S. Jeong, K.B. Kwon, S.O. Ka, H.Y. Jang, and J.W. Park Sulfuretin protects against cytokine-induced β-cell damage and prevents streptozotocin-induced diabetes Exp Mol Med 42 2010 628 638
29. M.Y. Song, G.S. Jeong, H.S. Lee, K.S. Kwon, S.M. Lee, and J.W. Park Sulfuretin attenuates allergic airway inflammation in mice Biochem Biophys Res Commun 400 2010 83 88
30. S. Tanaka, and H. Nakano NF-κB2 (p100) limits TNF-α-induced osteoclastogenesis J Clin Invest 119 2009 2879 2881
31. T. Tomita, E. Takeuchi, N. Tomita, R. Morishita, M. Kaneko, and K. Yamamoto Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor κB decoy oligodeoxynucleotides as a gene therapy Arthritis Rheum 42 1999 2532 2542 (Pubitemid 30327169)
32. M.P. Vincenti, C.I. Coon, and C.E. Brinckerhoff Nuclear factor κB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1β-stimulated synovial fibroblasts Arthritis Rheum 41 1998 1987 1994 (Pubitemid 28506689)
33. G. Xuzhu, M. Komai-Koma, B.P. Leung, H.S. Howe, C. McSharry, and I.B. McInnes Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function Ann Rheum Dis 71 2012 129 135
34. H. Yamanaka, Y. Matsuda, M. Tanaka, W. Sendo, H. Nakajima, and A. Taniguchi Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis Arthritis Rheum 43 2000 852 858